Conclusively, these findings revealed that the infiltration level of pro-tumorigenic CCL5+ TAMs cells could serve as an independent predictor for evaluating the immunoevasive TME and clinical outcomes of ccRCC. The gene discussed is CCL5; the disease is nonpapillary renal cell carcinoma.